New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

2

U.S. CDC to weigh rare clot risk with J&J’s Covid-19 vaccine as use paused

A U.S. health advisory panel on April 14 is set to review six reported cases of rare blood clots in women who received Johnson & Johnson’s Covid-19 vaccine one day after federal regulators paused the use of the shot to assess the issue.

4

AstraZeneca’s drug Tagrisso gets China nod for early lung cancer

AstraZeneca Plc said on April 14 that China’s health regulator expanded the use of Tagrisso, the British drugmaker’s lung cancer treatment, in patients with a type of lung cancer when diagnosed at an early stage.

5

U.S. FDA Grants Accelerated Approval to Trodelvy for Treatment of Metastatic Urothelial Cancer

The U.S. Food and Drug Administration granted accelerated approval of Gilead Sciences Inc.’s Trodelvy (sacituzumab govitecan-hziy) for use in adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and either a programmed death receptor-1 or a programmed death-ligand 1 inhibitor.

9

J&J Covid-19 vaccine delay will not impact U.S. vaccination plan: White House

The pause of Johnson & Johnson’s Covid-19 vaccine will not slow U.S. vaccination efforts, the White House COVID-19 coordinator said on April 13, adding that officials were working to reschedule people with other shots made by Pfizer and Moderna.

10

MAHF Moves Awards Dinner to 2022 to Ensure Safety

The Medical Advertising Hall of Fame announced on April 13 the postponement of its annual dinner to ensure the safety of the MAHF’s constituents. The 2021 inductees – Risa Bernstein, Maris Schilling, and Ronal Souza – will be honored at the 2022 dinner.